Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,446 total articles
BOS Better Online Solutions Ltd., a Nasdaq-listed company specializing in supply chain technologies across aerospace, defense, industrial, and retail sectors, announced its strategic initiative to expand its RFID division from retail into Israel's defense market. This move seeks to diversify revenue streams and leverage stable defense sector demand…
Orange County Bancorp, Inc. (NASDAQ: OBT) was recognized for the first time by Keefe, Bruyette & Woods (KBW) as one of 17 banks on the 2026 Bank Honor Roll, highlighting its consistent and strong earnings growth over the past decade. The company reported a record $41.6 million net income in 2025, a nearly 50% increase from the previous year, alongs…
DoubleVerify (NYSE: DV) announced the launch of AI-powered pre-screen content controls on Meta Threads, allowing advertisers to avoid unsuitable content before ads are served. This complements their earlier post-bid brand suitability measurements, providing a comprehensive approach to media quality and brand protection. Powered by their AI classifi…
H2O America has appointed Michael Ambrozewicz as its vice president of communications. Ambrozewicz brings extensive experience from consumer-facing companies and will lead the company’s communications strategy, supporting its mission to provide sustainable and high-quality water services.
Emergent BioSolutions has received regulatory approval from the Saudi Food and Drug Authority to register its ACAM2000 vaccine for the prevention of smallpox and mpox in high-risk individuals. This follows a recent approval in Singapore for an expanded indication to include mpox prevention. The vaccine is a critical product in global biodefense pre…
Autonomix Medical, Inc. announced that two abstracts highlighting its innovative transvascular nerve-targeting platform have been accepted for presentation at EuroPCR 2026. The presentations focus on pain mitigation in pancreatic cancer and precision-guided peripheral nerve modulation, underscoring growing clinical interest. The company’s platform …
Dogwood Therapeutics initiated a Phase 2b long-term extension study of Halneuron®, evaluating its safety and efficacy over 12 additional weeks to support upcoming FDA submissions and planned Phase 3 trials for chemotherapy-induced neuropathic pain (CINP). Initial 4-week Phase 2b results showed positive pain reduction effects, reinforcing the potent…
Clearmind Medicine Inc. has signed a research agreement with the Hebrew University of Jerusalem to conduct a 12-month preclinical study examining the metabolic efficacy of MEAI (CMND-100) in combination with and following tirzepatide treatment in diet-induced obese mice. The study aims to explore potential additive or synergistic effects to improve…
Scienture Holdings, Inc. announced Q1 2026 financial results showing a significant 449% increase in revenue year-over-year to $56 thousand and a substantial gross margin expansion to 95.6%, driven primarily by increased sales of ArbliTM, an innovative liquid formulation of losartan. The company also secured important patents for ArbliTM and REZENOP…
Marex Group plc announced the successful completion of its consent solicitation for amendments to its 6.404% Senior Notes due 2029. These amendments align the terms of the notes with recently issued senior notes, allowing a new Bermuda-based parent company to assume obligations under the notes following a proposed redomiciliation from England and W…
Teva Pharmaceutical Industries Ltd. received an upgrade from Fitch Ratings, moving its credit rating to investment grade BBB- with a stable outlook. This upgrade highlights Teva's successful transformation efforts focused on growth through innovative and biosimilar products, improved financial flexibility, and operational efficiencies. Fitch also u…
Quantum Cyber N.V., a Nasdaq-listed autonomous defense technology company, announces the creation of Quantum Drones Corporation, a new Nevada-based subsidiary focused on U.S. government procurement in autonomous drone warfare and advanced defense technologies. With experienced leadership in federal government and defense sectors, the subsidiary aim…
Silexion Therapeutics received Israeli regulatory approval and submitted a Clinical Trial Application in Germany to initiate a Phase 2/3 clinical trial of its lead RNAi therapy SIL204 targeting KRAS-driven pancreatic cancer. The trial is planned to start in Q2 2026 involving multiple European sites alongside Israel. The company also reported increa…
Arbor Realty Trust successfully redeemed $787 million of outstanding notes from its legacy CLO 17, transferring approximately $1.21 billion of assets into repurchase facilities with JPMorgan Chase that offer lower pricing and increased leverage. This transaction has created $132.3 million in additional liquidity and improved return metrics for the …
Oragenics, Inc. reports active enrollment and dosing in its Phase IIa clinical trial of ONP-002 for concussion and mild traumatic brain injury in Australia, progress toward U.S. IND submission, and a signed Letter of Intent to license a complementary CNS-related medical device. Financially, the company holds $6.1 million in cash and continues opera…
Fortress Biotech announced that its CEO, Lindsay A. Rosenwald, M.D., will participate in a fireside chat at the A.G.P. Annual Virtual Healthcare Conference on May 20, 2026. The company highlighted its diverse portfolio spanning oncology, dermatology, and rare diseases, along with strategic partnerships with leading research institutions and biophar…
SunCar Technology Group Inc. forecasts a net income of $1 million and revenue of $128 million for Q1 2026, marking its third consecutive quarter of profitability and a 25% increase in revenue compared to Q1 2025. This significant improvement highlights the company's growth and success in leveraging AI-powered auto insurance and services in China.
Draganfly Inc. announced an agreement to acquire substantially all assets of Skip Dynamix, a developer of ultra-low-cost, mass-producible fixed-wing unmanned aerial systems designed for long-range ISR, electronic warfare, and one-way missions. This acquisition strategically enhances Draganfly's defense portfolio and positions the company in the fas…
Alpha Tau Medical Ltd., a Nasdaq-listed oncology therapeutics company pioneering Alpha DaRT cancer therapy, announced CFO Raphi Levy's participation in several investor conferences including H.C. Wainwright, Rothschild & Co Redburn Radiopharma, and Lytham Partners in May 2026. These events feature presentations, fireside chats, and 1-on-1 meetings …
Navitas Semiconductor announced it will showcase its latest gallium nitride (GaN) and silicon carbide (SiC) power semiconductor products at PCIM 2026. The new offerings target AI data center power delivery, energy and grid infrastructure, and industrial electrification. Highlighted products include highly efficient GaNFast FETs, advanced SiC device…
Fusion Fuel Green PLC (Nasdaq: HTOO) announced an Extraordinary General Meeting scheduled for June 8, 2026, proposing three resolutions: the acquisition of Royal Uranium Inc., conversion of Series A Convertible Preferred Shares into ordinary shares, and changing the company name to Fusion Elements plc. The Board unanimously recommends approval, pos…
Critical Metals Corp. announced a definitive agreement to acquire all issued shares and options of European Lithium Ltd. through two interdependent schemes under Australian law. The acquisition aims to consolidate 100% ownership of the Tanbreez rare earth project, reduce shareholder dilution, increase public float, and enhance Critical Metals’ bala…
Victoria’s Secret & Co. issued a shareholder letter showcasing significant value creation and operational momentum under CEO Hillary Super since August 2024, with a total shareholder return of 141%. The company reported strong financial results in fiscal 2025 including accelerated sales growth, improved profitability, and brand expansion. Managemen…
A newly published randomized controlled trial in the Journal of the American Academy of Dermatology demonstrates that STRATA Skin Sciences' XTRAC 308-nm excimer laser, combined with oral JAK inhibitors, achieves unprecedented repigmentation response rates in pediatric vitiligo patients, with strong safety and quality-of-life benefits. This validate…
Alto Ingredients, Inc., a NASDAQ-listed producer and distributor specializing in renewable fuels, essential ingredients, and specialty alcohols, announced its participation in the Craig-Hallum 23rd Annual Institutional Investor Conference on May 28, 2026. The company's President & CEO and CFO will hold one-on-one investor meetings, highlighting eng…
